-Bruce M Spiegelman Researcher Activity Profile

Research Author Detailed Information 

Bruce M Spiegelman Publication Rate By Year

Bruce M Spiegelman has published 1 paper(s) in 2005, 4 paper(s) in 2006, 11 paper(s) in 2007, 5 paper(s) in 2008, for a total of 21 research publications in total.

Bruce M Bm Spiegelman Author Information

LAST NAME: spiegelman

FIRST NAME: Bruce M

INITIALS: bm

AFFILIATION:

Papers

Bruce M Spiegelman's Publication Record

1. Synergy between PPARgamma ligands and platinum-based drugs in cancer. Year Published: 2007
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
2. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Year Published: 2005
Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E18-580, Cambridge, MA 02139, USA.
3. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Year Published: 2006
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
4. PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Year Published: 2006
Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.
5. Defects in energy homeostasis in Leigh syndrome French Canadian variant through PGC-1alpha/LRP130 complex. Year Published: 2006
Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
6. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Year Published: 2006
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
7. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Year Published: 2007
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
8. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Year Published: 2007
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
9. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. Year Published: 2007
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
10. Transcriptional control of brown fat determination by PRDM16. Year Published: 2007
Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, 1 Jimmy Fund Way, Boston, MA 02115, USA.
11. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. Year Published: 2007
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
12. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. Year Published: 2007
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
13. Cell differentiation. Year Published: 2007
Department of Biochemistry, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
14. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Year Published: 2007
Dana-Farber Cancer Institute, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
15. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Year Published: 2007
Dana-Farber Cancer Institute, Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
16. Transcriptional control of energy homeostasis through the PGC1 coactivators. Year Published: 2008
Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
17. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Year Published: 2008
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA. zarany1@partners.org
18. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1{alpha} and oxidative phosphorylation. Year Published: 2008
Dana Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115.
19. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Year Published: 2008
Dana Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
20. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Year Published: 2008
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA. zarany1@partners.org
21. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. Year Published: 2007
Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.